A 60-Second Guide To What Brokers Are Telling Their Clients This Morning


Let’s take a look at analysts’ morning research notes.


  • Exxon (XOM): Downgraded to equalweight. We no longer believe the shares could outperform the peers over the next 12-18 months primarily because it will likely underperform other energy stocks in a bullish oil price scenario,  lack of near-term organic production growth through 2012 and valuation is not compelling compared to other mega-cap integrated oil companies.
  • Frontier Oil: Downgraded to underweight.


  • Bruker Corporation: upgraded to buy from neutral. It has critical mass and more margin potential. We are giving it a target price of $21.
  • General Electric: Upgraded to buy from neutral because of improving visibility. The target price was moved from $19 to $23.
  • Financials: UBS has upgraded the entire financial sector and downgraded healthcare. 

Societe Generale

  • ProShares UltraShort Financials: Upgrade to buy from hold. Re-rating set to continue as it is progressively closing the profitability gap with its peers.
  • Manpower: Upgrade to buy from hold. It has more attractive valuation, more positive momentum in its non-truck business and speculative appeal should allow it to outperform Volvo.


  • Advanced Micro Devices: Upgrade to buy from neutral. We believe it is one of the few companies in the semiconductor sector that will generate positive margin leverage this year.

JMP Securities:

  • Upping estimate on Apple to $400

Click here to see 10 unusual stocks moving this morning >

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.

Tagged In